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Because coronary heart disease is the leading cause of death
in the industrialized world (1), many clinical investigations
of purported cardiac risk factors and new treatments focus
on death as a primary end point. It is intuitively appealing to
attempt to better understand the association between an
exposure of interest and mortality by determining cause of
death, particularly differentiating between cardiac and non-
cardiac causes. This is usually done by reviewing death
certificates or, less often, medical records.
The use of “cardiac death” instead of all-cause death as an
end point in clinical investigation is, we believe, hazardous
for many reasons. In reality, data obtained from death
certificates or from medical records are haphazard, biased
and often grossly inaccurate. Notwithstanding these con-
cerns, determination of cause of death is inherently difficult
owing to the presence of concurrent comorbid illnesses, a
low autopsy rate and an inadequate understanding of com-
plex disease processes. Coronary heart disease may, in fact,
be present and significant at the time of death, and yet not
be the primary reason a patient may die. The ultimate result
of using specific causes of death as an end point is that
“softness” is introduced into a study that otherwise would be
based on the strength of the “hardest” end point of all:
all-cause mortality.
Data that are typically obtained as part of high-quality
prospective clinical investigations or trials are carefully and
systematically obtained, with great efforts made to maintain
consistent prespecified definitions, to reduce risk for errors,
to minimize missing data elements and to avoid potential
biases of ascertainment (2). This cannot be said for data
obtained from death certificates or medical records (3), even
when incorporated into formalized “classification commit-
tees” (4). Clinically important data may be missing because
of clerical errors and because they are recorded by busy,
harried practitioners who are not vested in high-quality
epidemiologic outcomes research. Physicians recording
death notes or death certificates often are unfamiliar with
patients’ long-term medical issues and may be confused by
changing medical terminology (5). From the clinical inves-
tigator’s point of view, there is no way that data quality and
data definitions can be adequately assessed and controlled.
Most physicians do not receive any kind of formal
training in filling out death certificates properly; it is very
common for physicians to confuse underlying cause of death
with mechanisms of death (6). The underlying cause of
death is “the disease or injury that initiated the train of
morbid events resulting in death;” this can be thought of as,
“In the absence of the underlying cause, the patient would
be alive today” (6). Conversely, a mechanism of death is “a
physiologic or biochemical disturbance produced by a cause
of death” (6). A study of 384 death certificates at a university
teaching hospital showed that 59% were incorrectly filled
out (3). Indeed, a very common error included recording a
mechanism of death (such as multiple organ system failure)
without providing an underlying cause (such as metastatic
lung cancer). Some death certificates simply stated that
patients died of “cardiac arrest” without any other informa-
tion added. Ultimately, everyone dies of cardiac arrest (3)!
Death certificate and death note data may suffer from
serious biases of ascertainment. Physicians who record these
data may well be aware of prior test results or treatment; this
knowledge may color their interpretations of cause of death,
particularly among patients with multiple complex illnesses.
Simply knowing that a patient had a stress nuclear study or
was enrolled in an unstable angina trial, for example, may
bias a physician into categorizing a death as cardiac when it
may not have been. A recent study, for example, demon-
strated a strong relationship between persistent minor elec-
trocardiographic (ECG) abnormalities and cardiac death as
assessed by death certificates (7). It is quite possible that the
physicians who filled out the death certificates knew that the
patients had abnormal ECGs and this might have biased
their assessments.
Assessment of the accuracy of death certificates is inher-
ently problematic because there is no standard for cause of
death, except perhaps for the autopsy, which is now infre-
quently performed. Nonetheless, a number of careful studies
have raised serious questions about the validity of death
certificates and clinical determinations of cause of death
(8–10). A study of 257 autopsied cases in Atlanta, Georgia
found improper recording on the original death certificate of
the underlying cause of death in 42% of cases, with
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underreporting of malignancies and overreporting of vascu-
lar deaths (9). Another study (10) of 272 randomly chosen
autopsies found a major disagreement between the death
certificate and autopsy in 29% of cases, leading to a change
of cause of death to an entirely different etiologic category.
The proportion of patients designated by the death certifi-
cate as dying of “circulatory” causes who had this confirmed
by autopsy was only 75%; conversely, among patients found
by autopsy to have died of circulatory causes, only 82% of
death certificates noted this.
A very recent report from the Framingham Heart
Study (11,12) compared causes of death among 2,683
decedents as identified by death certificates and by a
physician panel. Of 942 patients listed by the death
certificate of dying from coronary heart disease, only 645
(67%) had this confirmed by the physician panel. The
situation was even worse for stroke, where the corre-
sponding positive predictive value of the death certificate
was only 59%. Inaccurate reporting of coronary heart
disease death was strongly related to increasing age:
among patients with ages of 65 to 74, 75 to 84 and $85,
differential rates of reported versus confirmed coronary
heart disease deaths were 18%, 31% and 109%, respec-
tively. Another noteworthy finding was that the physician
panel could not confidently state a cause of death in 9%
of patients; among these the death certificate listed
coronary heart disease as the cause of death in 51%. The
investigators cite this finding as suggesting that physi-
cians may use the diagnosis of coronary heart disease as a
“default” (11).
Even when a cause of death seems obvious, careful
study may reveal gross inaccuracies. For example, a study
of 109 deaths among patients with implantable defibril-
lators found that 17 were identified on clinical grounds as
being due to “sudden cardiac death” (13). On the basis of
autopsy and interrogation of the defibrillators, sudden
death could only be confirmed in seven patients (42%).
Furthermore, six patients died of noncardiac causes,
including pulmonary embolism, cerebral infarction and
ruptured aortic aneurysm.
Even if cardiac death could be accurately distinguished
from noncardiac deaths, failure to use all-cause death as the
primary end point may lead to inappropriate interpretations
of data (4). If a particular type of observation or treatment
is in fact associated with a lower likelihood of cardiac death,
but is also associated with higher rates of noncardiac death,
neither patients nor investigators should be comforted. In
contrast, if there is no difference in noncardiac deaths
among different patient groups, the use of all-cause mortal-
ity would only bias results toward the null hypothesis, much
like nondifferential misclassification bias. Thus, any ob-
served differences in all-cause mortality reflect at least as
great a difference in cardiac mortality. This is indeed what
was observed in the recent study of minor ECG changes
and death: minor ECG changes strongly predicted all-cause
death, but to a somewhat less degree than “cardiac death”
(7). Indeed, focus on cause-specific, rather than all-cause
mortality, as an end point can lead to serious confusion, as
in, for example, the controversy regarding cholesterol low-
ering and violent death or suicide (14,15) before the
publication of the 4S Study (16). Another example would be
the question of whether amiodarone should be used as a
prophylactic agent, because a large trial demonstrated no
effects on all-cause mortality, although a reduction in
“arrhythmic deaths” was noted (4,17).
As Miss Buttercup in Gilbert and Sullivan’s HMS Pin-
afore said when revealing a case of mistaken identity,
“Things are seldom what they seem; skim milk masquerades
as cream.” Careful clinical investigators require high-quality
data for analyses; therefore, they should not accept inher-
ently inaccurate, unsystematic and biased data derived from
death certificates and medical records. Even when records
are properly filled out, determination of cause of death can
be very difficult, particularly among elderly patients with
multiple diseases. Rather, clinical investigators should rely
on all-cause death as an objective, unbiased end point that
is of primary interest to everyone in the general public and,
similarly, should be of primary interest to medical profes-
sionals as well.
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